China News Service, August 9th. According to Taiwan's "China Times" report, the Taiwan Epidemic Command Center has changed to adopt the "quick test positive is confirmed" policy from May 26, and the new crown quick screening agent has become a test for Taiwanese to detect whether they are infected. It is an important discriminant tool, but the price of quick screening agent remains high.
Taiwan's "Consumer Foundation" pointed out on the 8th that the authorities set a price of 100 yuan (New Taiwan dollar, the same below) for each dose, which has virtually become the market minimum price, and should return to the market mechanism as soon as possible.
Taiwan's "Consumer Foundation" collected the prices of quick-screening agents from 94 pharmacies on the market, and found that the highest price for one dose was 315 yuan and the lowest was 120 yuan. The average price of a single "nasal quick-screening agent" in the market was 160.94 yuan. The price of "saliva quick screening agent" is 164.58 yuan. The average price of commercially available quick screening agents is 60% to 65% higher than the government's allotment price. The highest price is 100 yuan per dose set by the government, a difference of 3.15 times. There is no quick screening agent below 100 yuan.
Huang Yiteng, chairman of Taiwan's "Consumer Foundation", said that when there was a lack of quick-screening agents in the market in May, the government forced the price of quick-screening agents to be set at 100 yuan per dose in order to increase manufacturers' willingness to import, to ensure the profits of importers, but when the supply The quantity has already met the market demand, and the price of quick-screening agents should return to the market mechanism. However, the government's implementation of the allotment system has produced a "price anchoring effect", which has become the market minimum price. The industry followed up and continued to increase the code.
A doctor from Shin Kong Hospital said that since the rapid screening reagents are sufficient, the public distribution price should be reviewed on a rolling basis, otherwise it will cause a heavy burden on consumers.
People surnamed Yang in Taipei City criticized that rapid screening reagents have become a necessity for people's livelihood, but the price remains high, and the market price is still uneven. For the DPP, the people are indeed the "softest" piece in their hearts.